This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, E. S. Articles by Shong, M. Search for Related Content PubMed PubMed Citation Articles by Park, E. S. Articles by Shong, M.

Involvement of JAK/STAT (Janus Kinase/Signal Transducer and Activator of Transcription) in the Thyrotropin Signaling Pathway

Department of Internal Medicine (E.S.P., H.K., J.M.S., S.J.P., H.K.C., K.W.L., Y.K.K., H.K.R., M.S.) Department of Anatomy (O.-Y.K.) School of Medicine Chungnam National University Taejon, 301–040, Korea
Department of Internal Medicine (B.Y.C.) School of Medicine Seoul National University Seoul, 110–744, Korea
Department of Biological Sciences (J.C.) Korea Advanced Institute of Science and Technology Taejon 305–701, Korea

TSH is an important physiological regulator of growth and function in thyroid gland. The mechanism of action of TSH depends on interaction with its receptor coupled to heterotrimeric G proteins. We show here that TSH induces the phosphorylation of tyrosine in the intracellular kinases Janus kinase 1 (JAK1) and -2 (JAK2) in rat thyroid cells and in Chinese hamster ovary (CHO) cells transfected with human TSH receptor (TSHR). The JAK family substrates STAT3 (signal transducers and activators of transcription) are rapidly tyrosine phosphorylated in response to TSH. We also find that JAK1, JAK2, and STAT3 coprecipitate with the TSHR, indicating that the TSHR may be able to signal through the intracellular phosphorylation pathway used by the JAK-STAT cascade. TSH increases STAT3-mediated promoter activity and also induces endogenous SOCS-1 (suppressor of cytokine signaling-1) gene expression, a known target gene of STAT3. The expression of a dominant negative form of STAT3 completely inhibited TSH-mediated SOCS-1 expression. These findings suggest that the TSHR is able to signal through JAK/STAT3 pathways.

This article has been cited by other articles:

				H. J. Kimura, R. Rocchi, M. A. Landek-Salgado, K. Suzuki, C. Y. Chen, M. Kimura, N. R. Rose, and P. Caturegli Influence of Signal Transducer and Activator of Transcription-1 Signaling on Thyroid Morphology and Function Endocrinology, July 1, 2009; 150(7): 3409 - 3416. [Abstract] [Full Text] [PDF]

				I. De Domenico, E. Lo, D. M. Ward, and J. Kaplan Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2 PNAS, March 10, 2009; 106(10): 3800 - 3805. [Abstract] [Full Text] [PDF]

				S. Tsui, V. Naik, N. Hoa, C. J. Hwang, N. F. Afifiyan, A. Sinha Hikim, A. G. Gianoukakis, R. S. Douglas, and T. J. Smith Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease J. Immunol., September 15, 2008; 181(6): 4397 - 4405. [Abstract] [Full Text] [PDF]

				J. H. D. Bassett, A. J. Williams, E. Murphy, A. Boyde, P. G. T. Howell, R. Swinhoe, M. Archanco, F. Flamant, J. Samarut, S. Costagliola, et al. A Lack of Thyroid Hormones Rather than Excess Thyrotropin Causes Abnormal Skeletal Development in Hypothyroidism Mol. Endocrinol., February 1, 2008; 22(2): 501 - 512. [Abstract] [Full Text] [PDF]

				N. N. Khodarev, A. J. Minn, E. V. Efimova, T. E. Darga, E. Labay, M. Beckett, H. J. Mauceri, B. Roizman, and R. R. Weichselbaum Signal Transducer and Activator of Transcription 1 Regulates Both Cytotoxic and Prosurvival Functions in Tumor Cells Cancer Res., October 1, 2007; 67(19): 9214 - 9220. [Abstract] [Full Text] [PDF]

				W. B. Kim, C. J Lewis, K. D McCall, R. Malgor, A. D Kohn, R. T Moon, and L. D Kohn Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms J. Endocrinol., April 1, 2007; 193(1): 93 - 106. [Abstract] [Full Text] [PDF]

				K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF]

				E. J. Park, K.-A. Ji, S.-B. Jeon, W.-H. Choi, I.-o. Han, H.-J. You, J.-H. Kim, I. Jou, and E.-H. Joe Rac1 Contributes to Maximal Activation of STAT1 and STAT3 in IFN-{gamma}-Stimulated Rat Astrocytes J. Immunol., November 1, 2004; 173(9): 5697 - 5703. [Abstract] [Full Text] [PDF]

				H. Kim, J. M. Suh, E. S. Hwang, D. W. Kim, H. K. Chung, J. H. Song, J. H. Hwang, K. C. Park, H. K. Ro, E.-K. Jo, et al. Thyrotropin-Mediated Repression of Class II Trans-Activator Expression in Thyroid Cells: Involvement of STAT3 and Suppressor of Cytokine Signaling J. Immunol., July 15, 2003; 171(2): 616 - 627. [Abstract] [Full Text] [PDF]

				J. M. Suh, J. H. Song, D. W. Kim, H. Kim, H. K. Chung, J. H. Hwang, J. M. Kim, E. S. Hwang, J. Chung, J.-H. Han, et al. Regulation of the Phosphatidylinositol 3-Kinase, Akt/Protein Kinase B, FRAP/Mammalian Target of Rapamycin, and Ribosomal S6 Kinase 1 Signaling Pathways by Thyroid-stimulating Hormone (TSH) and Stimulating type TSH Receptor Antibodies in the Thyroid Gland J. Biol. Chem., June 6, 2003; 278(24): 21960 - 21971. [Abstract] [Full Text] [PDF]

				J. D. Curlewis, S. P. Tam, P. Lau, D. H. L. Kusters, J. L. Barclay, S. T. Anderson, and M. J. Waters A Prostaglandin F2{alpha} Analog Induces Suppressors of Cytokine Signaling-3 Expression in the Corpus Luteum of the Pregnant Rat: A Potential New Mechanism in Luteolysis Endocrinology, October 1, 2002; 143(10): 3984 - 3993. [Abstract] [Full Text] [PDF]

				A. Bell, A. Gagnon, P. Dods, D. Papineau, M. Tiberi, and A. Sorisky TSH signaling and cell survival in 3T3-L1 preadipocytes Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1056 - C1064. [Abstract] [Full Text] [PDF]

				G. D. Frank, S. Saito, E. D. Motley, T. Sasaki, M. Ohba, T. Kuroki, T. Inagami, and S. Eguchi Requirement of Ca2+ and PKC{delta} for Janus Kinase 2 Activation by Angiotensin II: Involvement of PYK2 Mol. Endocrinol., February 1, 2002; 16(2): 367 - 377. [Abstract] [Full Text] [PDF]

				H. Kim, T.-H. Lee, Y. S. Hwang, M. A. Bang, K. H. Kim, J. M. Suh, H. K. Chung, D.-Y. Yu, K.-K. Lee, O-Y. Kwon, et al. Methimazole As an Antioxidant and Immunomodulator in Thyroid Cells: Mechanisms Involving Interferon-gamma Signaling and H2O2 Scavenging Mol. Pharmacol., November 1, 2001; 60(5): 972 - 980. [Abstract] [Full Text] [PDF]

				E.-K. Jo, H. Kanegane, S. Nonoyama, S. Tsukada, J.-H. Lee, K. Lim, M. Shong, C.-H. Song, H.-J. Kim, J.-K. Park, et al. Characterization of Mutations, Including a Novel Regulatory Defect in the First Intron, in Bruton's Tyrosine Kinase Gene from Seven Korean X-Linked Agammaglobulinemia Families J. Immunol., October 1, 2001; 167(7): 4038 - 4045. [Abstract] [Full Text] [PDF]